(updated with correction)
Brookhaven Science Associates LLC, Upton, N.Y., is overhauling the investment options lineup of its two defined contribution plans, confirmed spokesman Jim Green.
The changes will take effect Nov. 11 and leave the plans with 19 investment options as well as a lifecycle fund lineup managed by TIAA-CREF.
The changes are the result of “an extensive review of the fund lineup to identify best-in-class options that will assist Brookhaven Lab participants in saving for retirement,” wrote Mr. Green in an e-mail.
Brookhaven Science Associates operates the Brookhaven National Laboratory for the U.S. Department of Energy’s Office of Science.
The plans are adding the American Funds EuroPacific Growth, Baron Small Cap, Columbia Dividend Income, Goldman Sachs Small Cap Value, J.P. Morgan Mid Cap Value, PIMCO Total Return, Vanguard Total Stock Market index and Wells Fargo Advantage Discovery funds.
As a result of the additions, the plans are removing eight investment options and a target-date fund lineup managed by Fidelity Investments, seven investment options managed by TIAA-CREF and six investment options managed by Vanguard Group.
Brookhaven Science Associates LLC Retirement Plan had $718 million in assets and Brookhaven Science Associates LLC 401(k) Plan had $255 million in assets, both as of Dec. 31, 2011, according the company’s most recent Form 5500 filing.
